API Product

Tamsulosin base

Product Status:
Under Development
Available Grades:
  • Standard
Regulatory Status:
Under Development
Production Sites:
  • Hovione Loures
Product Type:
  • α1 receptor antagonist
CAS Number:
Modes of Application:
  • Oral
Common Indications:
  • Benign prostatic hyperplasia
Last Inspection:
FDA May 2018

Hovione offers stable cGMP Tamsulosin Base for development trials.



This is not to be construed as a representation of non-infringement or as an offer to sell in those countries where such would constitute an infringement of third parties’ patent rights.

Related files

Hovione Product Portfolio
pdf (84.51 KB)